An overview of Cenduit IRT's accelerated response to the challenge of digitally enabling sites for COVID-19 therapeutic and vaccine trials. Cenduit IRT is a leader in developing standard processes for IRT study design and has been employing a design tool since 2018.
Power your decentralized trial with an agile randomization and trial supply management solution that supports supply flexibility and optimization as well as adaptable direct to patient options.
Technology informed by unparalleled Decentralized Trials (DCT) operational experience and delivered at global scale.
Ease the burden on your sites and make it easier and more appealing for patients to enroll and remain engaged.
Combine data science, technology, and analytics driven by artificial intelligence to support new efficiencies and business insights -- without additional capital investment.
.svg){kind=icon}
